Evidence map›Paper›PMID 19667111›Full record

Trial reportArteriosclerosis, thrombosis, and vascular biology2009

Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans.

Neda Rasouli, Aiwei Yao-Borengasser, Vijayalakshmi Varma, Horace J Spencer, Robert E McGehee, Charlotte A Peterson, Jawahar L Mehta, Philip A Kern

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Arteriosclerosis, thrombosis, and vascular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Insulin Resistance and Inflammation.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. Gut microbiota and obesity: New insights.Frontiers in nutrition · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Neda RasouliCentral Arkansas Veterans Healthcare System, 111J, 4300 West 7th Street, Little Rock, AR 72205, USA. Rasoulineda@uams.edu
Aiwei Yao-Borengasser
Vijayalakshmi Varma
Horace J Spencer
Robert E McGehee
Charlotte A Peterson
Jawahar L Mehta
Philip A Kern
Central Arkansas Veterans Healthcare System · US

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Verruca Vulgaris--Skin Test &Candida /Mumps AntigenM01RR014288 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI PONNAPPAN, USHA · 1999 to 2006
$11.1M
THROMBOSPONDIN1 MEDIATES MACROPHAGE INFILTRATION INTO ADIPOSE TISSUE AND PROMOTEP20RR021954 · NCRR · UNIVERSITY OF KENTUCKY · PI ECKHARDT, ERIK · 2008 to 2011
$8.3M
Mechanisms Underlying Metabolic Syndrome in ObesityR01DK071349 · NIDDK · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A, PETERSON, CHARLOTTE A. · 2005 to 2013
$2.3M
Regulation of lipoprotein lipase in adipocytesR37DK039176 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI KERN, PHILIP A · 2006 to 2011
$1.8M
REGULATION OF LIPOPROTEIN LIPASE IN HUMAN ADIPOCYTESR01DK039176 · NIDDK · UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK · PI KERN, PHILIP A · 1993 to 2005
$1.6M
Mechanisms underlying metabolic syndrome in obesityR01DK071277 · NIDDK · UNIV OF ARKANSAS FOR MED SCIS · PI KERN, PHILIP A · 2005 to 2008
$848k
REGULATION OF LIPOPROTEIN LIPASE IN HUMAN ADIPOCYTESR29DK039176 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI KERN, PHILIP A · 1988 to 1990
–
NCATS NIH HHS UL1 TR001998NCRR NIH HHS M01 RR014288NCRR NIH HHS M01RR14288NCRR NIH HHS P20 RR021954NIDDK NIH HHS DK 39176NIDDK NIH HHS DK 71277NIDDK NIH HHS DK 71349NIDDK NIH HHS R01 DK039176NIDDK NIH HHS R01 DK071277NIDDK NIH HHS R01 DK071349NIDDK NIH HHS R37 DK039176
6 · The paper itself

Abstract

objectiveScavenger receptors play crucial roles in the pathogenesis of atherosclerosis, but their role in insulin resistance has not been explored. We hypothesized that scavenger receptors are present in human adipose tissue resident macrophages, and their gene expression is regulated by adiponectin and thaizolidinediones. METHODS AND

resultsThe gene expression of scavenger receptors including scavenger receptor-A (SRA), CD36, and lectin-like oxidized LDL receptor-1 (LOX-1) were studied in subcutaneous adipose tissue of nondiabetic subjects and in vitro. Adipose tissue SRA expression was independently associated with insulin resistance. Pioglitazone downregulated SRA gene expression in adipose tissue of subjects with impaired glucose tolerance and decreased LOX-1 mRNA in vitro. Macrophage LOX-1 expression was decreased when macrophages were cocultured with adipocytes or when exposed to adipocyte conditioned medium. Adding adiponectin neutralizing antibody resulted in a 2-fold increase in LOX-1 gene expression demonstrating that adiponectin regulates LOX-1 expression.

conclusionsAdipose tissue scavenger receptors are strongly associated with insulin resistance. Pioglitazone and adiponectin regulate gene expression of SRA and LOX-1, and this may have clinical implications in arresting the untoward sequalae of insulin resistance and diabetes, including accelerated atherosclerosis.

Indexed as

Insulin ResistanceAdipocytesAdiponectinAdultAgedCD36 AntigensCell LineCoculture TechniquesDown-RegulationFemaleHumansHypoglycemic AgentsMacrophagesMaleMetforminMiddle AgedAdiponectinADIPOQ protein, humanCD36 AntigensHypoglycemic AgentsMetforminOLR1 protein, humanPioglitazoneReceptors, ScavengerRNA, MessengerScavenger Receptors, Class AScavenger Receptors, Class EThiazolidinediones

Identifiers

PMID19667111
PMCPMC2755066
OpenAlexW2096137529

What OpenQuestion holds

Texttitle and abstract
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.